Ocufenac Suspension 0.10% contains Nepafenac, a non-steroidal anti-inflammatory drug (NSAID) specifically formulated for ophthalmic use. This prescription eye drop is designed to reduce inflammation, pain, and discomfort associated with ocular conditions, particularly after cataract surgery. Nepafenac works directly at the site of inflammation in the eye, providing targeted relief without systemic side effects commonly associated with oral NSAIDs.

Ocufenac Suspension 0.10% is a prodrug, meaning it is converted into its active form, amfenac, once it penetrates ocular tissues. This unique feature allows the medication to effectively inhibit cyclooxygenase (COX) enzymes in the eye, reducing prostaglandin synthesis. Prostaglandins are chemical mediators responsible for inflammation, pain, and swelling. By suppressing their production, Nepafenac helps alleviate post-surgical discomfort and prevent complications such as cystoid macular edema.

This ophthalmic suspension is particularly beneficial for patients undergoing cataract extraction or other intraocular procedures. It helps reduce inflammation, minimize post-operative pain, and support faster recovery, improving overall patient comfort and visual outcomes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features

• Active Ingredient – Nepafenac 0.10%: Potent NSAID for targeted ocular anti-inflammatory action.
• Reduces Ocular Inflammation: Helps control post-surgical swelling and irritation.
• Relieves Pain and Discomfort: Alleviates post-operative ocular pain.
• Prodrug Formulation: Converts to active amfenac in the eye for maximum efficacy.
• Ophthalmic Suspension: Ensures precise delivery to ocular tissues.

Indications

Ocufenac Suspension 0.10% is indicated for:

• Reduction of inflammation following cataract surgery

• Prevention of cystoid macular edema after intraocular surgery

• Relief of ocular pain and discomfort associated with post-surgical inflammation

The product should be used under ophthalmologist supervision, following the recommended dosing schedule to maximize efficacy and minimize risks.

Mechanism of Action

Nepafenac is a non-steroidal anti-inflammatory agent that inhibits cyclooxygenase (COX-1 and COX-2) enzymes in ocular tissues. COX enzymes are responsible for the conversion of arachidonic acid into prostaglandins, which mediate inflammation, pain, and edema. By blocking prostaglandin synthesis, Nepafenac reduces inflammatory responses, alleviates pain, and minimizes tissue swelling.

As a prodrug, Nepafenac penetrates the cornea efficiently and is converted by ocular hydrolases into amfenac, its active form. This targeted activation ensures high efficacy at the site of inflammation while reducing systemic absorption and potential side effects.

Dosage and Administration

• Instill one drop into the affected eye(s) three times daily, or as directed by an ophthalmologist.

• Begin therapy one day before surgery and continue for up to 2–3 weeks post-operatively, as prescribed.

• Avoid contact with fingers or other surfaces to prevent contamination.

• Wash hands before and after application.

• Do not wear contact lenses while using this suspension unless advised by the ophthalmologist.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

Ocufenac Suspension 0.10% is generally well tolerated. Possible side effects may include transient burning, stinging, or redness upon instillation. Severe reactions such as eye pain, swelling, or vision changes should be reported immediately.

Patients with known hypersensitivity to Nepafenac, other NSAIDs, or any component of the formulation should avoid use. Careful monitoring is recommended in patients with pre-existing ocular conditions or those taking other ophthalmic medications.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

With proper use, Ocufenac Suspension 0.10% provides effective post-surgical anti-inflammatory relief, promotes faster recovery, and enhances visual comfort after cataract and other intraocular procedures.